[Latest] Global Paclitaxel Injection Market Size/Share Worth USD 11.4 Billion by 2030 at a 13% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 30, 2023 06:30 ET
|
Custom Market Insights
Austin, TX, USA, May 30, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Paclitaxel Injection Market Size, Share, Growth Analysis Report By Indication...
HOOKIPA to Present a Trial in Progress Poster on its Prostate Cancer Phase 1/2 Clinical Trial at ASCO
April 26, 2023 11:30 ET
|
HOOKIPA Pharma Inc.
NEW YORK and VIENNA, Austria, April 26, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary...
Koelis Announces New Products at American Urology Association (“AUA”) Meeting
May 11, 2022 08:00 ET
|
Koelis
GRENOBLE, France and PRINCETON, N.J., May 11, 2022 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a leader and innovator in the care of prostate cancer, announced today...
Curium Initiates ECLIPSE, a Phase 3 Clinical Trial For Its Investigational Lu 177 PSMA I&T
October 27, 2021 02:15 ET
|
Curium
St. Louis, MO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Curium announced today that the Company has received a Study May Proceed letter from the U.S. Food and Drug Administration (FDA) to begin its Phase 3...
AB Science annonce que les résultats de l'étude AB12003 du masitinib dans le cancer de la prostate ont été présentés lors du congrès annuel 2021 de l'American Urological Association
September 13, 2021 12:04 ET
|
AB Science
COMMUNIQUE DE PRESSE LES RESULTATS DE L’ETUDE AB12003 DU MASITINIB DANS LE CANCER DE LA PROSTATE ONT ETE PRESENTES LORS DU CONGRES ANNUEL DE L’AMERICAN UROLOGICAL ASSOCIATION ET ONT ETE PUBLIES DANS...
AB Science announced today that results from masitinib study AB12003 in prostate cancer have been presented at the 2021 American Urological Association
September 13, 2021 12:04 ET
|
AB Science
PRESS RELEASE RESULTS FROM MASITINIB STUDY AB12003 IN PROSTATE CANCER PRESENTED AT THE AMERICAN UROLOGICAL ASSOCIATION ANNUAL MEETING WITH ABSTRACT PUBLISHED IN JOURNAL OF UROLOGY Paris, 13...
ProstaMend Reviews: Negative Side Effects or Real Prostate Pills? 2021 Review
March 12, 2021 13:41 ET
|
2021Review.com
Chicago, March 12, 2021 (GLOBE NEWSWIRE) -- ProstaMend is a daily prostate supplement that reduces its size and helps consumers reduce the number of times they go to the bathroom throughout their...
Shedir Pharma, an Italian Health and Wellness Company, Develops Nutritional Supplement for Prostate Functionality
December 27, 2019 10:40 ET
|
Shedir Pharma
BOCA RATON, FL, Dec. 27, 2019 (GLOBE NEWSWIRE) -- If a man lives long enough, he will probably have prostate issues. Millions of men, especially those over 50, have enlarged prostates. Prostate...